trimethyloxamine has been researched along with Primary Peritonitis in 3 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Zhang, L | 1 |
Xie, F | 1 |
Tang, H | 1 |
Zhang, X | 1 |
Hu, J | 1 |
Zhong, X | 1 |
Gong, N | 1 |
Lai, Y | 1 |
Zhou, M | 1 |
Tian, J | 1 |
Zhou, Z | 1 |
Xie, L | 1 |
Hu, Z | 1 |
Zhu, F | 1 |
Jiang, J | 1 |
Nie, J | 2 |
Chang, D | 1 |
Xu, X | 1 |
Yang, Z | 1 |
Ma, T | 1 |
Dong, J | 1 |
DeLano, FA | 1 |
Chow, J | 1 |
Schmid-Schönbein, GW | 1 |
3 other studies available for trimethyloxamine and Primary Peritonitis
Article | Year |
---|---|
Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.
Topics: Adult; Animals; Cell Death; Cytokines; Epithelium; Female; Gastrointestinal Microbiome; Glucose; Hum | 2022 |
Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.
Topics: Biomarkers; Cardiovascular Diseases; Humans; Kidney Failure, Chronic; Oxides; Peritoneal Dialysis; P | 2022 |
Volatile Decay Products in Breath During Peritonitis Shock are Attenuated by Enteral Blockade of Pancreatic Digestive Proteases.
Topics: Animals; Chromatography, Gas; Intestinal Mucosa; Methylamines; Peptide Hydrolases; Peritoneum; Perit | 2017 |